Terrific journalism on a troubling topic |

Posted By

Gary Schwitzer is the founder and publisher of HealthNewsReview. He has covered health care news almost exclusively since 1973. Here is his online bio of him. I’ve tweeted like this @garyschwitzer or so @HealthNewsRevu.

Terrific journalism on a troubling topic |Charles Piller writes in Science, “Blots On a Field? A neuroscience image sleuth finds signs of fabrication in scores of Alzheimer’s articles, threatening a reigning theory of the disease.”

It is a terrific piece of journalism that raises questions about a long unknown theory about Alzheimer’s disease. The new questions are fueled by allegations of fraud in key research. One key quote:

“The immediate, obvious damage is wasted NIH funding and wasted thinking in the field because people are using these results as a starting point for their own experiments,” says Stanford University neuroscientist Thomas Südhof, a Nobel laureate and expert on Alzheimer’s and related conditions.

Jeremy Olson of the StarTribune put the new allegations in the context of a “complicated legacy” at the University of Minnesota Medical School. Except:

Despite a remarkable history of life-saving inventions and surgical accomplishments, the U also has a legacy of research stars being implicated in scandals.

The late Dr. S. Charles Schulz stepped down as U psychiatry chair in 2015 amid claims by a grieving family that their son, who died by suicide, was coercively recruited into a schizophrenia drug trial.

Duplicated images and errors forced the correction of a 2002 Nature study, led by Dr. Catherine Verfaillie, claiming that certain adult stem cells possessed flexible abilities to grow and develop other cell types.

The late Dr. John Najarian was a pioneer in organ transplantation who elevated the U’s global profile, but he faced federal sanctions in the 1990s related to illicit sales of an experimental anti-rejection medication that improved transplant outcomes.

Leave a Comment